The Potential of Combining Tubulin-Targeting Anticancer Therapeutics and Immune Therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Potential of Combining Tubulin-Targeting Anticancer Therapeutics and Immune Therapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 3, Pages 586
Publisher
MDPI AG
Online
2019-01-30
DOI
10.3390/ijms20030586
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Docetaxel promotes the generation of anti-tumorigenic human macrophages
- (2018) Camilla Rydberg Millrud et al. EXPERIMENTAL CELL RESEARCH
- NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis
- (2018) Ariella Glasner et al. IMMUNITY
- Immune Checkpoint Inhibitor Toxicity in 2018
- (2018) Douglas B. Johnson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Natural killer cells and anti-tumor immunity
- (2017) Sandra E. Nicholson et al. MOLECULAR IMMUNOLOGY
- The benefits of immunotherapy combinations
- (2017) Charles Schmidt NATURE
- Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance
- (2017) Alessandra Zingoni et al. Frontiers in Immunology
- The immune system in cancer metastasis: friend or foe?
- (2017) Louise M.E. Janssen et al. Journal for ImmunoTherapy of Cancer
- Pro-Inflammatory Effects of Colchicine on Macrophages Stimulated with Atherogenic Stimuli in Vitro
- (2016) N. Schwarz et al. Heart Lung and Circulation
- Innate immune mediators in cancer: between defense and resistance
- (2016) Pedro Berraondo et al. IMMUNOLOGICAL REVIEWS
- P1.46: Phase I Study of Nivolumab + Nab-Paclitaxel in Solid Tumors: Preliminary Analysis of the Non-Small Cell Lung Cancer Cohort
- (2016) Ben George et al. Journal of Thoracic Oncology
- Progress in adjuvant chemotherapy for breast cancer: an overview
- (2015) Jesus Anampa et al. BMC Medicine
- Colchicine Significantly Reduces Incident Cancer in Gout Male Patients
- (2015) Ming-Chun Kuo et al. MEDICINE
- Colchicine—Update on mechanisms of action and therapeutic uses
- (2015) Ying Ying Leung et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Tubb3 regulation by the Erk and Akt signaling pathways: a mechanism involved in the effect of arginine ADP-ribosyltransferase 1 (Art1) on apoptosis of colon carcinoma CT26 cells
- (2015) Ming Xiao et al. TUMOR BIOLOGY
- Cracking the (tubulin) code of mitosis
- (2015) Marin Barisic et al. Oncotarget
- Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition
- (2015) Martina Di Modica et al. Oncotarget
- Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
- (2014) Edward B Garon et al. LANCET
- How Taxol/paclitaxel kills cancer cells
- (2014) Beth A. Weaver MOLECULAR BIOLOGY OF THE CELL
- Selective Depletion of Regulatory T Cell Subsets by Docetaxel Treatment in Patients with Nonsmall Cell Lung Cancer
- (2014) Jie-Yao Li et al. Journal of Immunology Research
- Microtubules and Their Role in Cellular Stress in Cancer
- (2014) Amelia L. Parker et al. Frontiers in Oncology
- T cell responses: naïve to memory and everything in between
- (2013) Nathan D. Pennock et al. ADVANCES IN PHYSIOLOGY EDUCATION
- M1 and M2 Macrophages: Oracles of Health and Disease
- (2013) Charles Mills CRITICAL REVIEWS IN IMMUNOLOGY
- Human dendritic cell subsets
- (2013) Matthew Collin et al. IMMUNOLOGY
- Monocytes in Coronary Artery Disease and Atherosclerosis
- (2013) Angie Ghattas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinoma
- (2013) Zu-Yau Lin et al. LIFE SCIENCES
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Nomenclature of monocytes and dendritic cells in blood
- (2010) L. Ziegler-Heitbrock et al. BLOOD
- Differential effects of Paclitaxel on dendritic cell function
- (2010) Justin John et al. BMC IMMUNOLOGY
- Development of Monocytes, Macrophages, and Dendritic Cells
- (2010) F. Geissmann et al. SCIENCE
- Classification of Chemotherapeutic Agents Based on Their Differential In vitro Effects on Dendritic Cells
- (2009) H. Tanaka et al. CANCER RESEARCH
- Dual Therapeutic Efficacy of Vinblastine as a Unique Chemotherapeutic Agent Capable of Inducing Dendritic Cell Maturation
- (2009) H. Tanaka et al. CANCER RESEARCH
- Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse
- (2008) Alain P. Vicari et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started